MED OPTAVIA: רווח צפוי

סמל ולוגו של המותג OPTAVIA (MED)

Medifast, Inc. (MED) is losing its pricing power due to new medical drugs, forcing the business to seek current development strategies. Estimated future earnings reflect market expectations, with the 0.00 level serving as a critical benchmark. The company is currently adapting its services to modern therapies, leveraging the synergy of meal replacements and coach support to retain loyal Optavia users.

MED: רווח נקי צפוי Medifast, Inc 04.07.2022 - 18.02.2025

MED (OPTAVIA): פילוחים אנליטיים ודוחות לפי אינדיקטורים

- מחיר ותחזית קונצנזוס למחירים:
אנליטיקה מסכמת של החברה:medifastinc.com, MED
מוצרים מוגמרים של Medifast Inc.

Medifast, Inc. (MED) efficiency is currently constrained by the negative impact of GLP-1 drugs, which are undermining operating profitability through rising per-coach costs. By analyzing earnings expectations, investors can synthesize long-term models and market consensus to assess the business's resilience to a narrowing forecast range and determine the potential for a price recovery once demand stabilizes.